Vincristine and Lomustine Induce Apoptosis and P21(WAF1) Up-regulation in Medulloblastoma and Normal Human Epithelial and Fibroblast Cells

Overview

Journal J Neurooncol

Publisher Springer

Date 2007 Dec 7

PMID 18058069

Citations 9

Authors

Zakia Shinwari

Pulicat S Manogaran

Salman A Alrokayan

Khaled A Al-Hussein

Abdelilah Aboussekhra

Affiliations

Soon will be listed here.

Abstract

Medulloblastomas arise in the cerebellum and are the most common pediatric primary malignant brain tumors. Currently, medulloblastoma patients are best treated with surgical removal of the tumor, adjuvant radiation therapy and chemotherapy. The chemotherapeutic agents that showed efficiency against medulloblastomas include lomustine and vincristine. However, the effects of these drugs on medulloblastomas as well as on other cell types is still not well defined. In the present report we present evidence that the cytotoxic effect of these drugs is not specific for medulloblastoma cells but includes also normal fibroblast and epithelial cells. We have also shown that vincristine and lomustine trigger apoptosis in all these cells through the mitochondrial pathway via decrease in the level of the anti-apoptosis proteins Bcl-2 and Bcl-xl, respectively. Intriguingly, the proportion of apoptotic cells induced in medulloblastoma and normal epithelial and fibroblastic cells was similar. In addition, vincristine induced low proportion of necrosis in medulloblastoma and normal fibroblast cells. Interestingly, while vincristine induced cell cycle delay in G2/M phase in normal as well as medulloblastoma cells, lomustine effect on the cell cycle was specific for medulloblastoma cells. Furthermore, we have shown that vincristine and lomustine up-regulated p21 protein level in a p53-independent manner. These results shed more light on the biological effects of vincristine and lomustine and show that lomustine is a more specific and potent anti-medulloblastoma agent.

Citing Articles

Targeting Apoptotic Pathway of Cancer Cells with Phytochemicals and Plant-Based Nanomaterials.

Wani A, Akhtar N, Mir T, Singh R, Jha P, Mallik S Biomolecules. 2023; 13(2).

PMID: 36830564 PMC: 9953589. DOI: 10.3390/biom13020194.

Prognostic biomarkers for predicting papillary thyroid carcinoma patients at high risk using nine genes of apoptotic pathway.

Arora C, Kaur D, Naorem L, Raghava G PLoS One. 2021; 16(11):e0259534.

PMID: 34767591 PMC: 8589158. DOI: 10.1371/journal.pone.0259534.

The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma.

Andrade A, Borges K, Suazo V, Geron L, Correa C, Castro-Gamero A Invest New Drugs. 2016; 35(1):26-36.

PMID: 27785591 DOI: 10.1007/s10637-016-0401-4.

The synergic effect of vincristine and vorinostat in leukemia in vitro and in vivo.

Chao M, Lai M, Liou J, Chang Y, Wang J, Pan S J Hematol Oncol. 2015; 8:82.

PMID: 26156322 PMC: 4504084. DOI: 10.1186/s13045-015-0176-7.

Revealing the molecular mechanism of gastric cancer marker annexin A4 in cancer cell proliferation using exon arrays.

Lin L, Huang H, Juan H PLoS One. 2012; 7(9):e44615.

PMID: 22970268 PMC: 3436854. DOI: 10.1371/journal.pone.0044615.

References

Di Leonardo A, Linke S, Clarkin K, Wahl G . DNA damage triggers a prolonged p53-dependent G1 arrest and long-term induction of Cip1 in normal human fibroblasts. Genes Dev. 1994; 8(21):2540-51. DOI: 10.1101/gad.8.21.2540. View

Johnstone R, Ruefli A, Lowe S . Apoptosis: a link between cancer genetics and chemotherapy. Cell. 2002; 108(2):153-64. DOI: 10.1016/s0092-8674(02)00625-6. View

Kumar K, Sonnemann J, Hong L, Buurman C, Adler F, Maass M . Histone deacetylase inhibitors, but not vincristine, cooperate with radiotherapy to induce cell death in medulloblastoma. Anticancer Res. 2007; 27(1A):465-70. View

Gnewuch C, Sosnovsky G . A Critical Appraisal of the Evolution of N-Nitrosoureas as Anticancer Drugs. Chem Rev. 1997; 97(3):829-1014. DOI: 10.1021/cr941192h. View

Scheithauer W, Ludwig H, Maida E . Acute encephalopathy associated with continuous vincristine sulfate combination therapy: case report. Invest New Drugs. 1985; 3(3):315-8. DOI: 10.1007/BF00179439. View

Jozwiak J, Grajkowska W, Wlodarski P . Pathogenesis of medulloblastoma and current treatment outlook. Med Res Rev. 2006; 27(6):869-90. DOI: 10.1002/med.20088. View

El-Deiry W, Tokino T, Velculescu V, Levy D, Parsons R, Trent J . WAF1, a potential mediator of p53 tumor suppression. Cell. 1993; 75(4):817-25. DOI: 10.1016/0092-8674(93)90500-p. View

Willis S, Adams J . Life in the balance: how BH3-only proteins induce apoptosis. Curr Opin Cell Biol. 2005; 17(6):617-25. PMC: 2930980. DOI: 10.1016/j.ceb.2005.10.001. View

Soini Y, Paakko P, Lehto V . Histopathological evaluation of apoptosis in cancer. Am J Pathol. 1998; 153(4):1041-53. PMC: 1853067. DOI: 10.1016/S0002-9440(10)65649-0. View

10.

Gartel A, Tyner A . Transcriptional regulation of the p21((WAF1/CIP1)) gene. Exp Cell Res. 1999; 246(2):280-9. DOI: 10.1006/excr.1998.4319. View

11.

Al-Mohanna M, Al-Khalaf H, Al-Yousef N, Aboussekhra A . The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet light. Nucleic Acids Res. 2006; 35(1):223-33. PMC: 1802571. DOI: 10.1093/nar/gkl1075. View

12.

Pizem J, Cor A, Zaletel L, Popovic M . Prognostic significance of apoptosis in medulloblastoma. Neurosci Lett. 2005; 381(1-2):69-73. DOI: 10.1016/j.neulet.2005.02.021. View

13.

Johnson D, Finch R, Lin Z, Zeiss C, Sartorelli A . The pharmacological phenotype of combined multidrug-resistance mdr1a/1b- and mrp1-deficient mice. Cancer Res. 2001; 61(4):1469-76. View

14.

Raffel C, Thomas G, Tishler D, Lassoff S, Allen J . Absence of p53 mutations in childhood central nervous system primitive neuroectodermal tumors. Neurosurgery. 1993; 33(2):301-5; discussion 305-6. DOI: 10.1227/00006123-199308000-00018. View

15.

Lefkowitz I, Packer R, Siegel K, Sutton L, Schut L, Evans A . Results of treatment of children with recurrent medulloblastoma/primitive neuroectodermal tumors with lomustine, cisplatin, and vincristine. Cancer. 1990; 65(3):412-7. DOI: 10.1002/1097-0142(19900201)65:3<412::aid-cncr2820650306>3.0.co;2-4. View

16.

Pingoud-Meier C, Lang D, Janss A, Rorke L, Phillips P, Shalaby T . Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin Cancer Res. 2003; 9(17):6401-9. View

17.

Lakin N, Jackson S . Regulation of p53 in response to DNA damage. Oncogene. 2000; 18(53):7644-55. DOI: 10.1038/sj.onc.1203015. View

18.

Sui M, Fan W . Combination of gamma-radiation antagonizes the cytotoxic effects of vincristine and vinblastine on both mitotic arrest and apoptosis. Int J Radiat Oncol Biol Phys. 2005; 61(4):1151-8. DOI: 10.1016/j.ijrobp.2004.12.028. View

19.

Fulda S, Debatin K . Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006; 25(34):4798-811. DOI: 10.1038/sj.onc.1209608. View

20.

Rutkauskiene G, Labanauskas L . Treatment of patients of high-risk group of medulloblastoma with the adjuvant lomustine, cisplatin, and vincristine chemotherapy. Medicina (Kaunas). 2006; 41(12):1026-34. View